UKRI has committed a major slice of funding to an expert team from Dundee University, which will also work on how to treat conditions such as Crohn’s and coeliac diseases
The government has awarded £30m in funding to support “life-changing” research into diseases including Alzheimer’s and Parkinson’s.
The money will support the Protein Phosphorylation and Ubiquitylation Unit from Dundee University work on new treatments for various fatal diseases. The team has already delivered more than 40 drugs, including one used to treat patients suffering from skin cancer, as well as working on treatments based on cell transmission.
It is understood that the research will also help deliver new responses for other conditions such as Crohn’s and coeliac disease.
Related content
- Academics believe AI could detect disease a decade before diagnosis
- Government-backed researchers claim AI cancer breakthrough
- NHS signs £1.4m deal for provision of rare and genetic disease database
Awarded by the Medical Research Council run by UK Research and Innovation, the cash injection will carry on for the next five years, “cementing” Scotland’s role in making Britain a “powerhouse” for life sciences, the government said.
Announcing the fund, science, innovation and technology secretary Peter Kyle said: “As we embark on a decade of national renewal, the higher education sector has a profound role to play in every piece of work we’ll need to do, to build a Britain that delivers for working people, from seizing the potential of clean energy to rebuilding the NHS. I will always champion our universities. They are society’s most powerful engines for innovation, aspiration, economic growth and the creation of better lives for all – which is why investing in their work, like this £30m in funding, is so important.”
Professor Dario Alessi, director of the Dundee University team added: “Our mission for the next five years will be to work with leading research centres, clinicians, and pharmaceutical companies to translate our discoveries into clinical progress and accelerate drug discovery. Whilst doing this research we aim to provide our staff with a unique training opportunity working in a collaborative multidisciplinary environment paying attention to improving culture and development best practices.”
This story is from our sister publication Holyrood which, is hosting the annual Public Sector Cloud Services, Infrastructure and AI conference in Edinburgh on 24 September. The Scottish Government recently launched its new Cloud Platform Service for the public sector, and this event will provide an opportunity for organisations to reflect on where they stand in their cloud migration and explore future strategies for the whole sector.
You helped me a lot by posting this article and I love what I’m learning.